The Clinical and Genetic Landscape of a French Multicenter Cohort of 2563 Epilepsy Patients Referred for Genetic Diagnosis
Open Access
- 8 August 2025
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 32 (8) , e70324
Abstract
Background: Epileptic disorders are a heterogeneous group of neurological conditions, with many cases linked to monogenic causes, particularly in developmental and epileptic encephalopathies (DEE). Identifying pathogenic variants aids treatment, prognosis, and family planning. In France, genetic testing is coordinated through the EpiGene network.Methods: We analyzed clinical and genetic data from 2563 epilepsy patients referred to four diagnostic labs (2016–2023). Epilepsy syndromes were classified via pre‐test questionnaires, and genotyping used various gene panels, including a 68‐gene core panel. Multivariate logistic regression assessed diagnostic rates and genotype–phenotype correlations.Results: Overall, 27.0% of patients had pathogenic/likely pathogenic variants, mainly within the core panel (24%). SCN1A and KCNQ2 were the most frequently mutated genes. Diagnostic yield varied by syndrome, with Dravet Syndrome Spectrum (DSS) and early‐infantile DEE (EIDEE) showing the highest rates (41% and 34%, respectively). Genetic heterogeneity differed across syndromes, from DSS (predominantly SCN1A) to Infantile Epileptic Spasms Syndrome (IESS, 12%), involving ≥ 26 genes. Outside DEE, self‐limited neonatal epilepsy (SeLNE) had the highest yield (50%). Earlier seizure onset was associated with a higher likelihood of a positive molecular diagnosis, whereas intellectual disability severity and drug resistance were not independently predictive of diagnostic outcome. Genotype–phenotype correlations highlighted that objective clinical data (e.g., age of onset) can outperform syndrome labels (e.g., EIDEE) in predicting diagnosis.Conclusion: This large cohort study refines the genetic landscape of epilepsy, informs classification challenges, and enhances genetic testing strategies, ultimately improving patient care and future research directions.Keywords
This publication has 37 references indexed in Scilit:
- PRRT2-related phenotypes in patients with a 16p11.2 deletionEuropean Journal of Medical Genetics, 2019
- Clinical and genetic spectrum of a large cohort of children with epilepsy in ChinaGenetics in Medicine, 2018
- Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disordersEpilepsia, 2018
- Rett Syndrome: A Genetic Update and Clinical Review Focusing on ComorbiditiesACS Chemical Neuroscience, 2017
- ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and TerminologyEpilepsia, 2017
- Resolution of Disease Phenotypes Resulting from Multilocus Genomic VariationNew England Journal of Medicine, 2017
- The evolving spectrum ofPRRT2-associated paroxysmal diseasesBrain, 2015
- GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunctionNature Genetics, 2013
- Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsyEpilepsia, 2012
- Phenotypic spectrum of 20 novel patients with molecularly defined supernumerary marker chromosomes 15 and a review of the literatureAmerican Journal of Medical Genetics Part A, 2010